Status:
COMPLETED
Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis
Lead Sponsor:
Military Hospital of Tunis
Conditions:
Adenoviral Keratoconjunctivitis
Eligibility:
All Genders
9+ years
Phase:
PHASE4
Brief Summary
Purpose: To compare efficiency and tolerance between topical 0.5% cyclosporine A and fluorometholone in patients with subepithelial corneal infiltrates (SEIs). Methods : A prospective double-blind ...
Detailed Description
This study was performed on the 72 eyes of 51 patients who were referred to our clinics for epidemic keratoconjunctivitis (EKC).Diagnosis of EKC was based on the constellation of clinical features. Th...
Eligibility Criteria
Inclusion
- patients having subepithelial infiltrates following epidemic keratoconjunctivites persisting for 14 days or more
Exclusion
- a past history of glaucoma or other anterior or posterior segment disease or surgery
- a chronic use of topical or systemic medications
- pregnancy,
- contact lens wearers,
- patients who couldn't attend at least two regimen visits
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04376970
Start Date
April 1 2017
End Date
April 1 2019
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Military Hospital of Tunis
Tunis, Illinois, Tunisia